Cardiac hypertrophy in athletes.

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Cardiac Imaging In Athletes.

Sudden cardiac death in athletes.

Sudden Cardiac Death in Athletes.

Potential Markers in Cardiac Hypertrophy?

Cardiac hypertrophy in early hypertension.

Reversing cardiac hypertrophy in hypertension.

Noninvasive evaluation of ventricular hypertrophy in professional athletes.

Redox regulation of cardiac hypertrophy.

Improvement of cardiac screening in amateur athletes.

Pathological vs. physiological cardiac hypertrophy.

Molecular aspects of cardiac hypertrophy.

Cardiac nonmyocytes in the hub of cardiac hypertrophy.

Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Cardiac arrest in athletes and resuscitation.

Sudden cardiac death in young athletes.

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.

Non-coding RNAs in cardiac hypertrophy.

Mechanotransduction in cardiac hypertrophy and failure.

The role of autophagy in cardiac hypertrophy.

Functions of autophagy in pathological cardiac hypertrophy.

Sodium-induced cardiac hypertrophy. Cardiac sympathetic activity versus volume load.

CD38 promotes angiotensin II-induced cardiac hypertrophy.

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.

Suggest Documents

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Cardiac Imaging In Athletes.

Sudden cardiac death in athletes.

Sudden Cardiac Death in Athletes.

Potential Markers in Cardiac Hypertrophy?

Cardiac hypertrophy in early hypertension.

Reversing cardiac hypertrophy in hypertension.

Noninvasive evaluation of ventricular hypertrophy in professional athletes.

Redox regulation of cardiac hypertrophy.

Improvement of cardiac screening in amateur athletes.

Pathological vs. physiological cardiac hypertrophy.

Molecular aspects of cardiac hypertrophy.

Cardiac nonmyocytes in the hub of cardiac hypertrophy.

Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Cardiac arrest in athletes and resuscitation.

Sudden cardiac death in young athletes.

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman.

Non-coding RNAs in cardiac hypertrophy.

Mechanotransduction in cardiac hypertrophy and failure.

The role of autophagy in cardiac hypertrophy.

Functions of autophagy in pathological cardiac hypertrophy.

Sodium-induced cardiac hypertrophy. Cardiac sympathetic activity versus volume load.

CD38 promotes angiotensin II-induced cardiac hypertrophy.

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.

Cardiac hypertrophy in athletes.

Recommend Documents

Follow Us